Oncolytics Biotech Inc. (ONC.TO)

CAD 0.77

(1.3%)

Revenue Summary of Oncolytics Biotech Inc.

  • Oncolytics Biotech Inc.'s latest annual revenue in 2023 was - CAD , down 0.0% from previous year.
  • Oncolytics Biotech Inc.'s latest quarterly revenue in 2024 Q2 was - CAD , down 0.0% from previous quarter.
  • Oncolytics Biotech Inc. reported a annual revenue of - CAD in annual revenue 2022, down 0.0% from previous year.
  • Oncolytics Biotech Inc. reported a annual revenue of - CAD in annual revenue 2021, down 0.0% from previous year.
  • Oncolytics Biotech Inc. reported a quarterly revenue of - CAD for 2024 Q1, down 0.0% from previous quarter.
  • Oncolytics Biotech Inc. reported a quarterly revenue of - CAD for 2023 FY, down 0.0% from previous quarter.

Annual Revenue Chart of Oncolytics Biotech Inc. (2023 - 1999)

Created with Highcharts 11.1.0YearsRevenue2000200220042006200820102012201420162018202020220 CAD1000000 CAD2000000 CAD3000000 CAD4000000 CAD5000000 CAD6000000 CAD

Historical Annual Revenue of Oncolytics Biotech Inc. (2023 - 1999)

Year Revenue Revenue Growth
2023 - CAD 0.0%
2022 - CAD 0.0%
2021 - CAD 0.0%
2020 - CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2015 - CAD 0.0%
2014 - CAD 0.0%
2013 - CAD -100.0%
2012 4.85 Million CAD 0.0%
2011 - CAD 0.0%
2010 - CAD 0.0%
2009 - CAD 0.0%
2008 - CAD 0.0%
2007 - CAD 0.0%
2006 - CAD -100.0%
2005 783.45 Thousand CAD 11.96%
2004 699.75 Thousand CAD 123.35%
2003 313.3 Thousand CAD 50.0%
2002 208.86 Thousand CAD 0.0%
2001 - CAD -100.0%
2000 310 Thousand CAD 30999900.0%
1999 1.00 CAD 0.0%

Peer Revenue Comparison of Oncolytics Biotech Inc.

Name Revenue Revenue Difference
Appili Therapeutics Inc. 827.4 Thousand CAD 100.0%
Eupraxia Pharmaceuticals Inc. - CAD NaN%
Helix BioPharma Corp. - CAD NaN%
Microbix Biosystems Inc. 16.51 Million CAD 100.0%
Medicenna Therapeutics Corp. - CAD NaN%
Satellos Bioscience Inc. - CAD NaN%
Sernova Corp. - CAD NaN%